These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Targeting DRP1 with Mdivi-1 to correct mitochondrial abnormalities in ADOA+ syndrome. Lin Y; Wang D; Li B; Wang J; Xu L; Sun X; Ji K; Yan C; Liu F; Zhao Y JCI Insight; 2024 Jun; 9(15):. PubMed ID: 38916953 [TBL] [Abstract][Full Text] [Related]
49. Optic disc morphology of patients with OPA1 autosomal dominant optic atrophy. Votruba M; Thiselton D; Bhattacharya SS Br J Ophthalmol; 2003 Jan; 87(1):48-53. PubMed ID: 12488262 [TBL] [Abstract][Full Text] [Related]
50. A novel AFG3L2 mutation close to AAA domain leads to aberrant OMA1 and OPA1 processing in a family with optic atrophy. Baderna V; Schultz J; Kearns LS; Fahey M; Thompson BA; Ruddle JB; Huq A; Maltecca F Acta Neuropathol Commun; 2020 Jun; 8(1):93. PubMed ID: 32600459 [TBL] [Abstract][Full Text] [Related]
51. Identification of copy number variation in the gene for autosomal dominant optic atrophy, OPA1, in a Chinese pedigree. Jin X; Chen YH; Liu Z; Deng Y; Li NN; Huang H; Qi M; Yi X; Zhu J Genet Mol Res; 2015 Sep; 14(3):10961-72. PubMed ID: 26400325 [TBL] [Abstract][Full Text] [Related]
53. OPA1 mutations in Japanese patients suspected to have autosomal dominant optic atrophy. Hamahata T; Fujimaki T; Fujiki K; Miyazaki A; Mizota A; Murakami A Jpn J Ophthalmol; 2012 Jan; 56(1):91-7. PubMed ID: 22042570 [TBL] [Abstract][Full Text] [Related]
54. Mitochondrial disorder with OPA1 mutation lacking optic atrophy. Milone M; Younge BR; Wang J; Zhang S; Wong LJ Mitochondrion; 2009 Jul; 9(4):279-81. PubMed ID: 19303950 [TBL] [Abstract][Full Text] [Related]
55. Genotype-phenotype heterogeneity of ganglion cell and inner plexiform layer deficit in autosomal-dominant optic atrophy. Rönnbäck C; Nissen C; Almind GJ; Grønskov K; Milea D; Larsen M Acta Ophthalmol; 2015 Dec; 93(8):762-6. PubMed ID: 26385429 [TBL] [Abstract][Full Text] [Related]
56. The association of autosomal dominant optic atrophy and moderate deafness may be due to the R445H mutation in the OPA1 gene. Amati-Bonneau P; Odent S; Derrien C; Pasquier L; Malthiéry Y; Reynier P; Bonneau D Am J Ophthalmol; 2003 Dec; 136(6):1170-1. PubMed ID: 14644237 [TBL] [Abstract][Full Text] [Related]
57. First report of OPA1 screening in Greek patients with autosomal dominant optic atrophy and identification of a previously undescribed OPA1 mutation. Kamakari S; Koutsodontis G; Tsilimbaris M; Fitsios A; Chrousos G Mol Vis; 2014; 20():691-703. PubMed ID: 24883014 [TBL] [Abstract][Full Text] [Related]
58. OPA1: How much do we know to approach therapy? Del Dotto V; Fogazza M; Lenaers G; Rugolo M; Carelli V; Zanna C Pharmacol Res; 2018 May; 131():199-210. PubMed ID: 29454676 [TBL] [Abstract][Full Text] [Related]
59. Human retinal organoids with an OPA1 mutation are defective in retinal ganglion cell differentiation and function. Lei Q; Xiang K; Cheng L; Xiang M Stem Cell Reports; 2024 Jan; 19(1):68-83. PubMed ID: 38101398 [TBL] [Abstract][Full Text] [Related]
60. Genotype-phenotype and OCT correlations in Autosomal Dominant Optic Atrophy related to OPA1 gene mutations: Report of 13 Italian families. Pretegiani E; Rosini F; Rufa A; Gallus GN; Cardaioli E; Da Pozzo P; Bianchi S; Serchi V; Collura M; Franceschini R; Bianchi Marzoli S; Dotti MT; Federico A J Neurol Sci; 2017 Nov; 382():29-35. PubMed ID: 29111013 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]